• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2011-2012: Survey Intelligence Product Image

Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2011-2012: Survey Intelligence

  • ID: 1942933
  • October 2011
  • 73 pages
  • iCD Research

Synopsis
- Analysis of opinions drawn from leading pharmaceutical industry executives
- Provides revenue growth expectations for the period 2011–2012
- Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business structure
- Analysis of the demand in emerging markets and growth expectations in developed countries
- Analysis of the changing business dynamics in the pharmaceutical industry
- Analysis of the challenges faced by buyers and suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how business strategies and practices in the pharmaceutical industry are set to change in 2011–12. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their READ MORE >

Note: Product cover images may vary from those shown



1 Executive Summary
2 Introduction
2.1 What is this report about?
2.2 Definitions
2.3 Methodology
2.4 Profile of survey respondents
2.4.1 Profile of buyer respondents
2.4.2 Profile of supplier respondents
3 Industry Dynamics
3.1 Revenue growth expectations
3.1.1 Revenue growth expectations by company type
3.1.2 Revenue growth expectations by region
3.1.3 Revenue growth expectations by turnover
3.1.4 Revenue growth expectations by senior level respondents
3.1.5 Revenue growth expectations: cross industry comparisons
3.2 Future developments in business structure
3.2.1 Future developments by buyers
3.2.2 Future developments by suppliers
3.3 M&A activity predictions
3.3.1 M&A activity predictions by buyers
3.3.2 M&A activity predictions by suppliers
3.3.3 M&A activity predictions by region
3.3.4 M&A activity predictions by company turnover
3.3.5 M&A activity expectations vs. expansion abroad
4 Pharmaceutical Market Growth Outlook
4.1 Demand in emerging markets
4.1.1 Demand in emerging markets by buyers
4.1.2 Demand in emerging markets by suppliers
4.1.3 Demand in emerging markets by region
4.1.4 Demand in emerging markets by company turnover
4.2 Growth expectations in developed countries
4.2.1 Growth expectations in developed countries by buyers
4.2.2 Growth expectations in developed countries by suppliers
4.2.3 Growth expectations in developed countries by region
4.2.4 Growth expectations in developed countries by company turnover
5 Threats And Opportunities for the Pharmaceutical Industry
5.1 Leading business concerns for 2011-2012
5.1.1 Leading business concerns for the period by company type
5.1.2 Leading business concerns by region
5.1.3 Leading business concerns by company turnover
5.2 Key supplier actions to maintain and win buyer business
5.2.1 Actions to maintain and secure buyer business by buyers
5.2.2 Actions to maintain and secure buyer business by region
5.2.3 Actions to maintain and secure buyer business by turnover
5.2.4 Actions to maintain and secure buyer business by procurement budget
5.2.5 Actions to maintain and secure buyer business by purchasing decision authority
6 Appendix
6.1 Methodology
6.2 Contact us
6.3 About ICD Research
6.4 Disclaimer

List of Tables
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2011
Table 2: Buyer Respondents by Job Role (%), 2011
Table 3: Buyer Respondents by Company Turnover (%), 2011
Table 4: Buyer Respondents by Total Number of Employees in Organizations (%), 2011
Table 5: Buyer Respondents by Region (%), 2011
Table 6: Supplier Respondents by Job Role (%), 2011
Table 7: Supplier Respondents by Company Turnover (%), 2011
Table 8: Supplier Respondents by Total Number of Employees in Organizations (%), 2011
Table 9: Supplier Respondents by Region (%), 2011
Table 10: Revenue Growth Optimism (%), 2009-2011
Table 11: Revenue Growth Optimism by Buyers (%), 2009-2011
Table 12: Revenue Growth Optimism by Suppliers (%), 2009-2011
Table 13: Revenue Growth Optimism by Region (%), 2009-2011
Table 14: Revenue Growth Optimism by Turnover (%), 2011
Table 15: Revenue Growth Optimism by Senior Level Respondents (%), 2011
Table 16: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry (%), 2011
Table 17: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011
Table 18: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry (%), 2011
Table 19: M&A Expectations Pharmaceutical Manufacturer Industry, 2009-2011
Table 20: M&A Expectations CRO and CMO Industry, 2009-2011
Table 21: M&A Expectations Drug Manufacturing Supplier Industry, 2009-2011
Table 22: M&A Expectations by Region, 2011
Table 23: M&A Expectations by Company Turnover, 2011
Table 24: M&A Activity Expectations vs. Expand Abroad (%), 2011
Table 25: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011
Table 26: Demand in Emerging Markets by CRO and CMO Industry (%), 2011
Table 27: Demand in Emerging Markets by Drug Manufacturing Supplier (%), 2011
Table 28: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer (%), 2011
Table 29: Growth Expectations in Developed Countries by CRO and CMO (%), 2011
Table 30: Growth Expectations in Developed Countries by Drug Manufacturing Supplier (%), 2011
Table 31: Leading Business Concerns (%), 2009-2010, 2010-2011,2011-2012
Table 32: Leading Business Concerns by Company Type (%), 2011-2012
Table 33: Leading Business Concerns by Region (%), 2011-2012
Table 34: Leading Business Concerns by Company Turnover (%), 2011-2012
Table 35: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2011
Table 36: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2011
Table 37: Actions to Maintain and Secure Buyer Business by Region (%), 2011
Table 38: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2011
Table 39: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2011

List of Figures
Figure 1: Revenue Growth Optimism (%), 2009-2011
Figure 2: Revenue Growth Optimism by Company Type(%), 2009-2011
Figure 3: Revenue Growth Optimism by Region (%), 2009-2011
Figure 4: Revenue Growth Optimism by Turnover (%), 2011
Figure 5: Revenue Growth Optimism by Senior Level Respondents (%), 2011
Figure 6: Company Revenue Growth Optimism: Cross Industry Comparisons (%), 2011
Figure 7: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry (%), 2011
Figure 8: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011
Figure 9: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry (%), 2011
Figure 10: M&A Expectations Pharmaceutical Manufacturer Industry, 2009-2011
Figure 11: M&A Expectations CRO and CMO Industry, 2009-2011
Figure 12: M&A Expectations Drug Manufacturing Supplier Industry, 2009-2011
Figure 13: M&A Expectations by Region, 2011
Figure 14: M&A Expectations by Company Turnover, 2011
Figure 15: Top Ten Growth Regions (%), 2011
Figure 16: Top Five Emerging Markets, 2011
Figure 17: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011
Figure 18: Demand in Emerging Markets by CRO and CMO Industry (%), 2011
Figure 19: Demand in Emerging Markets by Region (%), 2011
Figure 20: Demand in Emerging Markets by Company Turnover (%), 2011
Figure 21: Top Five Developed Countries Targeted for Growth, 2011
Figure 22: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer (%), 2011
Figure 23: Growth Expectations in Developed Countries by CRO and CMO (%), 2011
Figure 24: Growth Expectations in Developed Countries by Drug Manufacturing Supplier (%), 2011
Figure 25: Growth Expectations in Developed Countries by Region (% 'Increase' Responses), 2011
Figure 26: Growth Expectations in Developed Countries by Turnover (% 'Increase' Responses), 2011
Figure 27: Leading Business Concerns (%), 2011-2012
Figure 28: Leading Business Concerns (%), 2011-2012
Figure 29: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2011
Figure 30: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2011
Figure 31: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2011
Figure 32: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2011

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos